Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Felici

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Transforming growth factor-beta signaling and regulatory T cellsGianluigi Ferretti, Alessandra Felici, Francesco Cognetti, et al.
Journal of the National Cancer Institute|August 31, 2007
Re: Ovarian ablation or suppression in premenopausal early breast cancer: results from the International Adjuvant Breast Cancer Ovarian Ablation or Suppression randomized trialGianluigi Ferretti, Alessandra Felici, Paolo Carlini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative diseaseGianluigi Ferretti, Alessandra Fabi, Alessandra Felici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Does CTLA4 influence the suppressive effect of CD25+CD4+ regulatory T cells?Gianluigi Ferretti, Alessandra Felici, Maria Simona Pino, et al.
Expert Review of Anticancer Therapy|December 21, 2012
Sequential therapy in metastatic clear cell renal carcinoma: TKI-TKI vs TKI-mTORAlessandra Felici, Emilio Bria, Giampaolo Tortora, et al.
Current Opinion in Obstetrics & Gynecology|January 16, 2007
HER2/neu role in breast cancer: from a prognostic foe to a predictive friendGianluigi Ferretti, Alessandra Felici, Paola Papaldo, et al.
Bone|May 26, 2007
Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasisGianluigi Ferretti, Alessandra Fabi, Paolo Carlini, et al.
The Oncologist|August 2, 2006
Adjuvant trastuzumab with docetaxel or vinorelbine for HER-2-positive breast cancerGianluigi Ferretti, Paola Papaldo, Alessandra Fabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
What is the biological significance of circulating blood levels of metalloproteinases?Gianluigi Ferretti, Alessandra Fabi, Paolo Carlini, et al.
The Oncologist|May 25, 2006
Trastuzumab combined with paclitaxel after doxorubicin and cyclophosphamide for operable HER2-positive breast cancerGianluigi Ferretti, Alessandra Felici, Paola Papaldo, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Transforming growth factor-beta signaling and regulatory T cellsGianluigi Ferretti, Alessandra Felici, Francesco Cognetti, et al.
Journal of the National Cancer Institute|August 31, 2007
Re: Ovarian ablation or suppression in premenopausal early breast cancer: results from the International Adjuvant Breast Cancer Ovarian Ablation or Suppression randomized trialGianluigi Ferretti, Alessandra Felici, Paolo Carlini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative diseaseGianluigi Ferretti, Alessandra Fabi, Alessandra Felici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Does CTLA4 influence the suppressive effect of CD25+CD4+ regulatory T cells?Gianluigi Ferretti, Alessandra Felici, Maria Simona Pino, et al.
Expert Review of Anticancer Therapy|December 21, 2012
Sequential therapy in metastatic clear cell renal carcinoma: TKI-TKI vs TKI-mTORAlessandra Felici, Emilio Bria, Giampaolo Tortora, et al.
Current Opinion in Obstetrics & Gynecology|January 16, 2007
HER2/neu role in breast cancer: from a prognostic foe to a predictive friendGianluigi Ferretti, Alessandra Felici, Paola Papaldo, et al.
Bone|May 26, 2007
Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasisGianluigi Ferretti, Alessandra Fabi, Paolo Carlini, et al.
The Oncologist|August 2, 2006
Adjuvant trastuzumab with docetaxel or vinorelbine for HER-2-positive breast cancerGianluigi Ferretti, Paola Papaldo, Alessandra Fabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
What is the biological significance of circulating blood levels of metalloproteinases?Gianluigi Ferretti, Alessandra Fabi, Paolo Carlini, et al.
The Oncologist|May 25, 2006
Trastuzumab combined with paclitaxel after doxorubicin and cyclophosphamide for operable HER2-positive breast cancerGianluigi Ferretti, Alessandra Felici, Paola Papaldo, et al.
Pageof 6